Logiscreen

RxSight Inc

$4.68
Market Cap 193.13M
ROE -17.0%
Gross Margin 76.1%
Debt/Equity 0.0
Current Ratio 10.2
Revenue QoQ -18.5%
EPS QoQ 0.9%
F-Score 2

About

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-4.17
vs median 35.63
P/B
0.73
vs median 2.25
ROE
-0.17
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics